The use of oral tacrolimus in a case of short bowel syndrome

Transplant International

Volumn 17, Issue 1, 2004, Pages 44-45

  Patel, Nilay ^a   Smith, Stuart ^a   Handa, Ashok ^a   Darby, Chris ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Oral immunosuppression; Short bowel syndrome; Tacrolimus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; IMIDAZOLE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MESENTERIC ARTERY; NEPHROTOXICITY; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFARCTION; KIDNEY TRANSPLANTATION; SHORT BOWEL SYNDROME; SPLANCHNIC CIRCULATION; TACROLIMUS;

EID: 1042279658     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00382.x     Document Type: Article

References (4)

1. Sen PK, Kinare G, Engineer SD, Parulkar GB (1963) The middle aortic syndrome. Brit Heart J 25:610
2. Novelli M, Muiesan P, Mieli-Vergani G, Dhawan A, Rela M, Heaton N (1999) Oral absorption of tacrolimus in children with intestinal failure due to short or absent bowel. Transpl Int 12:463
3. Thielke J, Martin J, Weber FL, Schroeder TJ, Goretsky S, Hanto DW (1998) Pharmacokinetics of tacrolimus and cyclosporine in short bowel syndrome. Liver Transpl Surg 5:432
4. Regazzi M, Alessiani M, Reggiani P, et al. (1997) Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplant Proc 29:1857